
Please try another search
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Kevin Hykes | 58 | 2022 | President, CEO & Director |
Mudit K. Jain | 56 | 2020 | Independent Director |
Martha Shadan | 69 | 2021 | Independent Director |
Kirk G. Nielsen | - | 2020 | Independent Director |
Joseph P. Slattery | 60 | 2008 | Independent Lead Director |
Mitchell C. Hill | 66 | 2024 | Independent Director |
Kevin J. Ballinger | 52 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review